Safety of resuming tumor necrosis factor inhibitors in ankylosing spondylitis patients concomitant with the treatment of active tuberculosis: A retrospective nationwide registry of the Korean Society of spondyloarthritis research
Hye Won Kim, Seong Ryul Kwon, Kyong Hee Jung, Seong Kyu Kim, Han Joo Baek, Mi Ryung Seo, So Young Bang, Hye Soon Lee, Chang Hee Suh, Ju Yang Jung, Chang Nam Son, Seung Cheol Shim, Sang Hoon Lee, Seung Geun Lee, Yeon Ah Lee, Eun Young Lee, Tae Hwan Kim, Yong Gil Kim, Kwi Young Kang, Mi Il KangBon San Koo, Dam Kim, You Jae Kim, Joong Gon Kim, Jin Ju Kim, Tae Jong Kim, Hyung Jin Kim, Hee Jung Ryu, Hyun Jeong Yoo, Ye Soo Park, Min Chan Park, Chang Bum Bae, Young Ho Seo, Duk Hyun Sung, Yoon Kyoung Sung, Ran Song, Kichul Shin, Dong Hyuk Sheen, Ji Min Oh, Tae Seok Yoo, Sang Yeob Lee, Sang Heon Lee, Seunghun Lee, Jaejoon Lee, Jae Myung Lee, Mi Kyoung Lim, Sung Hae Chang, Hyemin Jeong, Soo Kyung Cho, Hyun Jung Cho, Mi La Cho, Young Bin Joo, Hoon Suk Cha, Seong Jae Choi, Ji Young Choi, Chan Bum Choi, Hyo Jin Choi, Seung Jae Hong, Ji Won Hwang, Seok Chan Hong
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Safety of resuming tumor necrosis factor inhibitors in ankylosing spondylitis patients concomitant with the treatment of active tuberculosis: A retrospective nationwide registry of the Korean Society of spondyloarthritis research'. Together they form a unique fingerprint.